References
- El-HaraziSMFeldmanRMControl of intra-ocular inflammation associated with cataract surgeryCurr Opin Ophthalmol20011214811150074
- RaoNARole of oxygen free radicals in retinal damage associated with experimental uveitisTrans Am Ophthalmol Soc1990887978501965620
- FlachAJThe incidence, pathogenesis and treatment of cystoid macular edema following cataract surgeryTrans Am Ophthalmol Soc19989655763410360304
- McColginAZHeierJSControl of intraocular inflammation associated with cataractsurgeryCurr Opin Ophthalmol20001113610724825
- WoodsACClinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory diseaseAm J Ophthalmol19503391325134914771206
- ArmalyMFEffect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eyeArch Ophthalmol19637048249114078870
- BeckerBIntraocular pressure response to topical corticosteroidsInvest Ophthalmol1965419820514283013
- CantrillHLPalmbergPFZinkHAWaltmanSRPodosSMBeckerBComparison of in vitro potency of corticosteroids with ability to raise intraocular pressureAm J Ophthalmol1975796101210171173539
- BodorNLoftssonTWuWMMetabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonatePharm Res1992910127512781448425
- BodorNBuchwaldPSoft drug design: general principles and recent applicationsMed Res Rev20002015810110608921
- DruzgalaPHochhausGBodorNSoft drugs – 10. Blanching activity and receptorbinding affinity of a new type of glucocorticoid: loteprednol etabonateJ Steroid Biochem Mol Biol19913821491542004037
- StewartRHorwitzBHowesJNovackGDHartKDouble-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1J Cataract Refract Surg19982411148014899818338
- LE Postoperative Study Group 2A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammationOphthalmology19981059178017869754192
- ComstockTLPaternoMRSinghAErbTDavisESafety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgeryClin Ophthalmol2011517718621383946
- DellSJLowryGMNorthcuttJAHowesJNovackGDHartKA randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitisJ Allergy Clin Immunol199810222512559723669
- LE Uveitis Study GroupControlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitisAm J Ophthalmol1999127553754410334346
- ShulmanDGLothringerLLRubinJMA randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitisOphthalmology199910623623699951491
- IlyasHSlonimCBBraswellGRFavettaJRSchulmanMLong-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitisEye Contact Lens2004301101314722462
- SheppardJDScoperSVSamudreSTopical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye diseaseJ Ocul Pharmacol Ther2010271232721133792
- FriedlaenderMHHowesJA double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group IAm J Ophthalmol199712344554649124242
- DruzgalaPWuWMBodorNOcular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyesCurr Eye Res199110109339371959381
- PflugfelderSCOphthalmic Preservatives: The Past, Present, and Future2008 Available from: http://www.candeocsc.com/Preservatives-Final-web.pdfAccessed August 26, 2011
- LinZLiuXZhouTA mouse dry eye model induced by topical administration of benzalkonium chlorideMol Vis20111725726421283525
- IchijimaHPetrollWMJesterJVCavanaghHDConfocal microscopic studies of living rabbit cornea treated with benzalkonium chlorideCornea19921132212251587129